Featured Studies

The National Institutes on Alcohol Abuse and Alcoholism (NIAAA) is recruiting heavy drinkers for a study to evaluate the safety of an investigational drug to treat signs and symptoms of alcohol associated liver damage. If you drink more than 20 alcoholic beverages per week, you may have this type of liver damage.

The National Institutes of Health (NIH) is conducting a research study of the causes and responses to treating multiple sclerosis (MS) and other brain and spine inflammatory conditions. Join this study if you have MS or a related disease. Although the study does not offer treatment options, your participation may help in future discoveries and inspire hope.

Malaria is a dangerous disease that impacts hundreds of millions of people in Africa, Asia, and Latin America. It can cause severe disease and even death. Researchers at NIH's Laboratory of Malaria Immunology and Vaccinology are seeking healthy volunteers to be part of a malaria vaccine research study.

A research study at the National Institutes of Health (NIH) is is investigating how dietary habits affect our intestinal microorganisms by studying the effects of Mediterranean-like unprocessed (CLEAN-MED) diet. Participants will be divided into two groups, depending on their interest in trying out the diet for 4 weeks or maintaining a new healthy diet over months, and will be provided with some foods. Participants will log the food they eat and answer questions about their diet throughtout the study. Food and research supplies and procedures are provided at no cost.

Do you... Find yourself constantly checking things? Spend lots of time ordering your belongings? Have unusual rituals or habits that seem unnecessary? Do you blurt out comments at inappropriate times, interrupt conversations or speak out of turn or feel you are overly impulsive? The National Human Genome Research Institute (NHGRI) is conducting an outpatient research study on the links between compulsivity, impulsivity and the developing brain in children and young adults.

After stem cell transplantation, some people develop hard-to-treat anemia (low red blood cells) or thrombocytopenia (low platelets). Cytopenia(s) or low blood cell counts make you weak, prone to bleeding and bruising, and dependent on blood product transfusions. Researchers at the National Institutes of Health (NIH) are testing the drug fostamatinib to see if it is safe to treat cytopenia(s) after stem cell transplantation. A physician referral is not required to participate.

Researchers at the National Institutes of Health are investigating the role of Near-Infrared Spectroscopy (NIRS) technologies as a monitoring tool for measuring oxygen levels, blood flow, and the make-up of skin and muscle in patients with sickle cell disease (SCD). In this study, researchers will compare NIRS measurements in people with and without SCD.